4.6 Review

Clinical significance of antinuclear antibodies in primary immune thrombocytopenia

期刊

BRITISH JOURNAL OF HAEMATOLOGY
卷 -, 期 -, 页码 -

出版社

WILEY
DOI: 10.1111/bjh.19069

关键词

antinuclear antibodies; epidemiology; immune thrombocytopenia; lupus

向作者/读者索取更多资源

There is inconsistency in guidelines regarding the usefulness of antinuclear antibodies (ANAs) dosage in the diagnosis of primary immune thrombocytopenia (ITP). This review provides an overview of the current understanding of ANA prevalence in patients with primary ITP and their potential role as biomarkers for ITP progression, treatment response, and increased risk of developing systemic lupus and thrombosis.
There are discrepancies across guidelines about whether the dosage of antinuclear antibodies (ANAs) is of use at the diagnosis of primary immune thrombocytopenia (ITP). This review describes the current knowledge about ANA prevalence in patients with primary ITP, and their potential usefulness as biomarkers for ITP evolution, response to treatments and increased risk of subsequent development of systemic lupus and thrombosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据